The effect of taurolidine on experimental thrombus formationKAPTANOGLU, Levent; KUCUK, Hasan Fehmi; COLAK, Elif et al.European journal of pharmacology. 2008, Vol 578, Num 2-3, pp 238-241, issn 0014-2999, 4 p.Article

The effects of taurolidine, a novel antineoplastic agent, on human malignant mesotheliomaNICI, Linda; MONFILS, Barbara; CALABRESI, Paul et al.Clinical cancer research. 2004, Vol 10, Num 22, pp 7655-7661, issn 1078-0432, 7 p.Article

Taurolidine lock : The key to prevention of recurrent catheter-related bloodstream infectionsJUREWITSCH, Brian; JEEJEEBHOY, Khursheed N.Clinical nutrition (Edinburgh). 2005, Vol 24, Num 3, pp 462-465, issn 0261-5614, 4 p.Article

Significant Reduction in Central Venous Catheter―related Bloodstream Infections in Children on HPN After Starting Treatment With Taurolidine Line LockCHU, Hui-Ping; BRIND, Joanne; TOMAR, Rajeev et al.Journal of pediatric gastroenterology and nutrition. 2012, Vol 55, Num 4, pp 403-407, issn 0277-2116, 5 p.Article

Taurolidine is effective in the treatment of central venous catheter-related bloodstream infections in cancer patientsKOLDEHOFF, M; ZAKRZEWSKI, J. L.International journal of antimicrobial agents. 2004, Vol 24, Num 5, pp 491-495, issn 0924-8579, 5 p.Article

The antibacterial drug taurolidine induces apoptosis by a mitochondrial cytochrome c-dependent mechanismZHIYONG HAN; RIBBIZI, Iole; PANTAZIS, Panayotis et al.Anticancer research. 2002, Vol 22, Num 4, pp 1959-1964, issn 0250-7005, 6 p.Article

Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparinMOLLER HANDRUP, Mette; FUURSTED, Kurt; FUNCH, Peter et al.APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 2012, Vol 120, Num 10, pp 794-801, issn 0903-4641, 8 p.Article

The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat modelOPITZ, I; VAN DER VEEN, H. C; BRAUMANN, C et al.Surgical endoscopy. 2003, Vol 17, Num 7, pp 1098-1104, issn 0930-2794, 7 p.Article

Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solutionBETJES, Michiel G. H; VAN AGTEREN, Madelon.Nephrology, dialysis, transplantation (Print). 2004, Vol 19, Num 6, pp 1546-1551, issn 0931-0509, 6 p.Article

Treatment of glioblastoma with intravenous taurolidine. First clinical experienceSTENDEL, Ruediger; PICHT, Thomas; SCHILLING, Andreas et al.Anticancer research. 2004, Vol 24, Num 2C, pp 1143-1147, issn 0250-7005, 5 p.Article

NMR STUDIES AND GC ANALYSIS OF THE ANTIBACTERIAL AGENT TAUROLIDINEKNIGHT BI; SKELLERN GG; SMAIL GA et al.1983; JOURNAL OF PHARMACEUTICAL SCIENCES; ISSN 0022-3549; USA; DA. 1983; VOL. 72; NO 6; PP. 705-707; BIBL. 10 REF.Article

The antiendotoxin agent taurolidine potentially reduces ischemia/ reperfusion injury through its metabolite taurineDODDAKULA, Kishore K; NEARY, Peter M; WANG, Jiang H et al.Surgery. 2010, Vol 148, Num 3, pp 567-572, issn 0039-6060, 6 p.Article

Peritoneal instillation of taurolidine or polihexanide modulates intestinal microcirculation in experimental endotoxemiaFRIELING, Helge; LAUER, Kai-Steffen; GRÜNDLING, Matthias et al.International journal of colorectal disease (Print). 2007, Vol 22, Num 7, pp 807-817, issn 0179-1958, 11 p.Article

Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locksOLTHOF, E. D; RENTENAAR, R. J; RIJS, A. J. M. M et al.Clinical nutrition (Edinburgh). 2013, Vol 32, Num 4, pp 538-542, issn 0261-5614, 5 p.Article

High doses of taurolidine inhibit advanced intraperitoneal tumor growth in ratsBRAUMANN, Chris; STUHLDREIER, Benedikt; BOBRICH, Eva et al.The Journal of surgical research. 2005, Vol 129, Num 1, pp 129-135, issn 0022-4804, 7 p.Article

Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignanciesDÜMICHEN, M. J; SEEGER, K; LODE, H. N et al.The Journal of hospital infection. 2012, Vol 80, Num 4, pp 304-309, issn 0195-6701, 6 p.Article

Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysisGALLIENI, M; CHIARELLI, G; OLIVI, L et al.Clinical nephrology. 2011, Vol 75, Num 1, pp 70-73, issn 0301-0430, 4 p.Article

The Tumor Suppressive Reagent Taurolidine Inhibits Growth of Malignant Melanoma : a Mouse ModelBRAUMANN, Chris; JACOBI, Christoph A; ROGALLA, Stephan et al.The Journal of surgical research. 2007, Vol 143, Num 2, pp 372-378, issn 0022-4804, 7 p.Article

TOLERANCE DE LA TAUROLIDINE, PAR VOIE LOCALE ET GENERALE, EN CHIRURGIE BILIO-PANCREATIQUE ET DIGESTIVEVANKEMMEL M; SCHERPEREEL P; ERB F et al.1983; MEDECINE ET CHIRURGIE DIGESTIVES; ISSN 0047-6412; FRA; DA. 1983; VOL. 12; NO 2; PP. 149-152; BIBL. 6 REF.Article

Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in ratsNESTLER, G; SCHULZ, H. U; SCHUBERT, D et al.Surgical endoscopy. 2005, Vol 19, Num 2, pp 280-284, issn 0930-2794, 5 p.Article

Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: A heparin-controlled prospective trialBISSELING, Tanya M; WILLEMS, Martine C; VERSLEIJEN, Michelle W et al.Clinical nutrition (Edinburgh). 2010, Vol 29, Num 4, pp 464-468, issn 0261-5614, 5 p.Article

Intra-Abdominal Use of Taurolidine or Heparin as Alternative Products to an Antiadhesive Barrier (Seprafilm) in Adhesion Prevention : An Experimental Study on MiceBAHADIR, Isamettin; ONCEL, Mustafa; KEMENT, Metin et al.Diseases of the colon & rectum. 2007, Vol 50, Num 12, pp 2209-2214, issn 0012-3706, 6 p.Article

Taurolidine 2% as an antimicrobial lock solution for prevention of recurrent catheter-related bloodstream infectionsJUREWITSCH, B; LEE, T; PARK, J et al.JPEN. Journal of parenteral and enteral nutrition. 1998, Vol 22, Num 4, pp 242-244, issn 0148-6071Article

Taurolidine lock solution in the secondary prevention of central venous catheter-associated bloodstream infection in home parenteral nutrition patientsTOURE, Abdoulaye; LAUVERJAT, Madeleine; PERALDI, Catherine et al.Clinical nutrition (Edinburgh). 2012, Vol 31, Num 4, pp 567-570, issn 0261-5614, 4 p.Article

UBER DIE PHARMAKOKINETIK VON TAUROLIN = SUR LA PHARMACOCINETIQUE DE LA TAUROLINESTEINBACH LEBBIN C; GANZ AJ; CHANG A et al.1982; ARZNEIMITTEL-FORSCHUNG; ISSN 0004-4172; DEU; DA. 1982; VOL. 32; NO 12; PP. 1542-1546; ABS. ENG; BIBL. 1 P.Article